MedPath
NMPA Approval

Rifaximin for Suspension

国药准字H20070309

March 8, 2022

国药准字H20070309

Drug Information

利福昔明干混悬剂

倩儿芬

口服混悬剂

0.2g

化学药品

March 8, 2022

Company Information

Applicant Company

扬州市江都区宜陵镇国泰路51号

Manufacturing Company

扬州市江都区宜陵镇国泰路51号(口服固体制剂三车间,口服固体制剂三车间片剂、干混悬剂生产线)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利福昔明干混悬剂 - NMPA 批准文号 | MedPath